The table below shows AETHLON MEDICAL INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$7.65M
-$10.13M
-$10.51M
-$9.77M
-$6.76M
-$5.20M
Capital expenditure
$0.00
$250.87K
$943.11K
$349.19K
$59.88K
$151.66K
Investing cash flow
$0.00
-$250.87K
-$943.11K
-$349.19K
-$59.88K
-$151.66K
Dividends paid
-
-
-
-
AEMD operating cash flow (10-K history)
AETHLON MEDICAL INC reported operating cash flow of -$7.65M for fiscal year 2025. That is up 24.5% from -$10.13M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$4.33M (FY 2016) to -$7.65M. Figures come from the company's audited annual reports as filed with the SEC.